A Supervised Prehabilitation Program for Patients with Pancreatic Cancer

What is the Purpose of this Study?

The purpose of this study is to evaluate the effects of a supervised prehabilitation exercise program in people with pancreatic cancer. Prehabilitation, or exercise prior to undergoing surgery or while concurrently undergoing treatment for cancer, has been shown to have beneficial effects for patients with cancer. In this study, researchers want to learn whether patients can regularly participate in an exercise program. The study will also assess the impact of the program on healthcare utilization, muscle mass, quality of life, physical activity, sleep, and post-operative outcomes when applicable. Participants will take part in a supervised, in-person exercise program 3 times per week for 6 weeks in a Cedars-Sinai gym facility. They will also receive a Fitbit to be worn continuously during the study, as well as complete surveys and exercise tests at specified timepoints.


Eligibility

  • * Pancreatic cancer diagnosis (any stage)
  • * Age ≥ 18 years
  • * Independent ambulation and activities of daily living (Discretion of referring/ treating oncologist)
  • * Godin-Shephard Leisure-Time Physical Activity Questionnaire score of ≤ 23
Show more

Where can I participate?

  • CS Cancer at Beverly Hills
  • CS Cancer at Cedars-Sinai Medical Center


More about this Clinical Trial

What is the full name of this clinical trial?

IIT2021-18-CHANG-PREHAB: A Supervised Prehabilitation Program for Patients with Pancreatic Cancer

Study Details
Disease Type/Condition

Pancreas

Principal Investigator

Chang, Philip

Co-Investigators

Alexandra (Alix) Sleight Warner, Andrew Hendifar, Arash Asher, Arsen Osipov, David Hoffman, Gillian Gresham, Jeremy Lorber, Jun Gong, Kamya Sankar, Kevin Scher

Age Group

Adult

Phase

N/A

IRB Number

STUDY00002551

ClinicalTrials.gov ID

NCT05692323

Key Eligibility
ClinicalTrials.gov

How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Pancreas

Principal Investigator

Chang, Philip

Age Group

Adult

Phase

N/A

IRB Number

IIT2021-18-CHANG-PREHAB

ClinicalTrials.gov ID

NCT05692323

Key Eligibility
ClinicalTrials.gov

Contact
Email
clinicaltrials@cshs.org